Last reviewed · How we verify

Zinc Gluconate 30 MG

University of Maryland, Baltimore · FDA-approved active Small molecule Quality 5/100

Zinc Gluconate 30 MG is a Small molecule drug developed by University of Maryland, Baltimore. It is currently FDA-approved.

At a glance

Generic nameZinc Gluconate 30 MG
SponsorUniversity of Maryland, Baltimore
ModalitySmall molecule
PhaseFDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Frequently asked questions about Zinc Gluconate 30 MG

What is Zinc Gluconate 30 MG?

Zinc Gluconate 30 MG is a Small molecule drug developed by University of Maryland, Baltimore.

Who makes Zinc Gluconate 30 MG?

Zinc Gluconate 30 MG is developed and marketed by University of Maryland, Baltimore (see full University of Maryland, Baltimore pipeline at /company/university-of-maryland-baltimore).

What development phase is Zinc Gluconate 30 MG in?

Zinc Gluconate 30 MG is FDA-approved (marketed).

Related